Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)

• Tomoyuki Kawada

Affiliations

Tomoyuki Kawada

Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan